TORONTO, June 25, 2015 /CNW/ - Bedrocan Cannabis Corp. ("Bedrocan" or "the Company") (TSXV: BED) announced its financial and operational results for the three month period ended April 30, 2015. Bedrocan Cannabis Corp's wholly owned subsidiary Bedrocan Canada Inc. is a Licensed Producer under Health Canada'sMarihuana for Medical Purposes Regulations (MMPR).

Q1 2016 Financial and Operational Highlights:

• Revenues of medicinal cannabis to authorized patients in Canada were $439,759 for the three month period ended April 30, 2015 ("Q1/2016"), compared to $94,812 for the three month period ended March 31, 2014.
• Gross profit was $170,858 for three months ended April 30, 2015 (Q1/2016) compared to$94,812 for the three month period ended March 31, 2014.
• Completed construction on schedule of its 52,000 square foot domestic production facility in the Greater Toronto Area (GTA).
• Received its second license from Health Canada to allow for the production of medicinal cannabis in the first six grow rooms of its new production facility.
• Was issued an import license from Health Canada to allow for the transfer
...